Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Trump may be mystery patient in odd case of 79yo getting experimental obesity drug" is generating significant coverage in the Business category, with 5 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The New Republic, Seeking Alpha, statnews.com and Ars Technica. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "Trump may be mystery patient in odd case of 79yo getting experimental obesity dr" trending?
Because 4 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug The Daily Beast · 2h ago
- Did Trump Get Special Access to Retatrutide? Mother Jones · 2h ago
- White House Denies Trump Was Given Exclusive Weight Loss Drug Forbes · 2h ago
- Remember That Time Trump Said He “Probably Should” Take Ozempic? The New Republic · 2h ago
- Lilly allows one-time access to next-gen obesity drug (update) Seeking Alpha · 2h ago
- Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program statnews.com · 2h ago
- Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com · 2h ago
- Trump may be mystery patient in odd case of 79yo getting experimental obesity drug Ars Technica · 2h ago
Topics
Related trends
Trump signs orders calling for powerful quantum computer, targeting 2028
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
What Trump’s Quantum Executive Orders Mean for IonQ and Infleqtion
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
US waives Iran sanctions, Trump says he will 'do what I have to' if Tehran misbehaves
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Israel fears Trump is strengthening Iran's hand in Lebanon
4 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Trump issues stark warning to Iran as Tehran credits Swiss talks with preventing Lebanon bloodshed
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Trump’s new standard deduction for 65+ Americans will benefit the rich
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.